With extensive updated information on everything from treatment of chronic pain to management of HIV infection in paediatric patients, AHFS (R) Drug Information (R) 2019 is a necessary addition to your pharmacy's resources.

With content supported by nearly 90,000 references and incorporating the advice of numerous subject matter experts, AHFS (R) Drug Information (R) 2019 helps you protect your patients and your practice. It is the only reference published by an American professional and scientific society-ensuring it is the most authoritative and best-selling reference trusted by pharmacists for over 60 years.

AHFS (R) Drug Information (R) 2019 contains the most trustworthy drug information available-all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Updates for this edition include:

Expanded and revised content throughout, featuring critical new monograph updates every year
Important updated monographs and references related to revised therapeutic guidelines, including revised recommendations for treatment of fungal infections (such as Candida auris infections) and chronic hepatitis C
Newly published information on breakthrough oncology drugs approved as part of the FDA's accelerated approval program
Dedicated coverage to orphan products
Interactions, adverse reactions, and cautions, including ongoing revisions addressing opiate safety issues and their role in pain management
Therapeutic recommendations supported by evidence from primary research
Extensive dosage and administration information
Pharmacology and pharmacokinetics
Prescription, OTC, ophthalmic and dermatologic drugs
Extensive off-label uses and related dosing options
Vaccines and other immunizing agents, including recommendations for travellers